Trials / Completed
CompletedNCT05651529
Acute Oral Ketones or Carbohydrate Supplement Modify Heart Function in Heart Failure?
Does Oral Intake of Beta-hydroxybutyrate Decrease Left Ventricular End-systolic Volume at Cardiac Magnetic Resonance in Patients With Heart Failure Compared to Carbohydrate Placebo?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- Université de Sherbrooke · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Does oral intake of exogenous ketone salt improve heart function measured by cardiac MRI in heart failure compared to oral intake of a carbohydrate placebo?
Detailed description
This study will help to quantify heart and kidney ketone uptake with or without an exogenous ketone salt in heart failure condition. Participants will have 2 different cardiac MRI to perform: 1. Fasting with exogenous ketone salt supplement 2. Fasting with exogenous carbohydrate supplement
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | exogenous ketone salt supplement | Dietary Supplement: Fasting water and with exogenous ketone salt supplement. Participants will have to take 1 doses of supplement 30 minutes before the scan. |
| DIETARY_SUPPLEMENT | exogenous carbohydrate supplement | Dietary Supplement: Fasting water and with exogenous carbohydrate supplement. Participants will have to take 1 doses of supplement 30 minutes before the scan. |
Timeline
- Start date
- 2022-12-16
- Primary completion
- 2025-12-16
- Completion
- 2025-12-16
- First posted
- 2022-12-15
- Last updated
- 2026-01-07
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT05651529. Inclusion in this directory is not an endorsement.